The Ophthalmology Times Group talked to an optometrist practice about their experience with ocular nutraceuticals
Study examines real-world treat-and-extend outcomes and background factors of macular atrophy
The study demonstrated that the number of injections needed gradually decreased during the follow-up period
PHOTON Results and Their Relation to DME Patients in Your Practice
John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.
EDI-OCT and CVI findings can shed light on choroidal vascular physiology following COVID-19 pneumonia
Investigators measured the choroidal structures using enhanced depth imaging optical coherence tomography
PULSAR Results and Their Relation to nAMD Patients in Your Practice
John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.
Advanced therapies in neovascular AMD and DMO: Experts weigh in
A clinician panel illuminates current treatment paradigms and best practices for reducing treatment burden
Renal dysfunction negatively impacts effect of diabetic macular oedema therapy
Additionally, the prognosis of macular oedema may help clinicians evaluate renal function, investigators reported